Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review

Table 1 Clinical trials evaluating the incidence of overall complications and post-ERCP pancreatitis

Author	Country	Year published	n	No. ERCP	Overall complications (%)	Post-ERCP pancreatitis (%)
Large prospective trials
Wang[20]	China	2009	2691	3178	7.92	4.31
Kapral[62]	Austrian	2008	NRa	3132	12.60	5.10
Dundee[23]	Australia	2007	563	700	5.71	3.71
Williams[24]	United Kingdom	2007	4561	5234	5.00	1.60
Bhatia[25]	India	2006	1497	1497	NRa	3.80
Cheng 2006 and Sherman 2003b[111,154]	United States	2006	1115	NRa	NRa	15.10
Andriulli[59]	Italy	2004	1127	1050	NRNRa	4.80
Christensen[13]	Denmark	2004	NRa	1177	15.90	3.80
Barthet	France	2002	658	1159	NRa	3.50
Vandervoort[10]	United States	2002	1223	1223	11.20	7.20
Freeman[58]	United States	2001	NRa	1963	NRa	6.70
Masci[35]	Italy	2001	2103	2044	4.95	1.80
DePalma[27]	Italy	1999	535	NRa	NRa	5.30
Deans[11]	United Kingdom	1997	958	1000	2.40	1.00
Johnson[28]	United States	1997	1979	NRa	NRa	10.40
Freeman[29]	United States and Canada	1996	2347	NRa	9.80	5.40
Loperfido[12]	Italy	1995	2769	NRa	4.00	1.30
Large retrospective trials
Cotton[29]	United States	2009	11497	NRa	4.00	2.60
Lukens[30]	United States	2009	2606	3924	3.12	0.97
Andriulli[31]	Italy	2007	16855	NRa	6.85	3.47
Cheon[60]	United States	2007	9872	14331	NRa	4.00

^aNot reported;

^bSame patient cohort; ERCP: Endoscopic retrograde cholangiopancreatography.